Nasdaq · CIK 0001567529
KMDA KAMADA LTD
Insider trading from SEC Form 4. Last filing 14 d ago. Close $8.08 on Oct 9, 2026, +29% from the 52-week low and -9% from the high.
KAMADA LTD (KMDA) has 29 SEC Form 4 filings on file from 19 insiders, the latest filed on Sep 29, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 2 open-market sells worth $1.7M, net -$1.7M.
2 open-market trades have been scored at KMDA. The newest: David Tsur (director) sold $187k of stock on Sep 14, 2026, filed Sep 17, 2026, scored 27 (weak). The largest of the 2 shown: David Tsur (director) sold $1.5M on Sep 7, 2026, scored 50 (moderate).
KMDA closed at $8.08 on Oct 9, 2026, 29% above its 52-week low and 9% below its 52-week high.
Last 90 days
Net insider value
-$1.7M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$1.7M by 1 insider
Insiders on file
19
with a Form 4 at this company
Price and insider trades, last year
KMDAOct 9, 2026 · close 8.08
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at KAMADA LTD, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | David Tsur director sell | $187k 22,827 shares | -5% | - | |
| 50Moderate | David Tsur director sell | $1.5M 177,173 shares | -29% | - |
Transactions
The newest 50 of 122 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Uri Botzer director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 14 d ago |
| Aug 27, 2026 | Ishay Davidi director, owner | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +26,500 | $0.00 | $0 | 26,500 | 14 d ago |
| Aug 27, 2026 | Lilach Asher-Topilsky director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +26,500 | $0.00 | $0 | 26,500 | 14 d ago |
| Aug 27, 2026 | Lilach Asher-Topilsky director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 14 d ago |
| Aug 27, 2026 | Ishay Davidi director, owner | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 14 d ago |
| Aug 27, 2026 | Uri Botzer director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 14 d ago |
| Aug 27, 2026 | Ishay Davidi director, owner | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 14 d ago |
| Aug 27, 2026 | Lilach Asher-Topilsky director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 14 d ago |
| Aug 27, 2026 | Amir London Chief Executive Officer | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +400,000 | $0.00 | $0 | 400,000 | 18 d ago |
| Aug 27, 2026 | Amir London Chief Executive Officer | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +400,000 | $0.00 | $0 | 400,000 | 18 d ago |
| Aug 27, 2026 | Boris Gorelik VP, BD and Strategic Programs | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +15,000 | $0.00 | $0 | 15,000 | 19 d ago |
| Aug 27, 2026 | Liron Reshef VP Human Resources | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +40,000 | $0.00 | $0 | 40,000 | 19 d ago |
| Aug 27, 2026 | Shavit Beladev VP Plasma Operations | AGrant or award Employee Stock Option(right to buy)derivativeindirect: Held by trustee | +15,000 | $0.00 | $0 | 15,000 | 19 d ago |
| Aug 27, 2026 | Karnit Goldwasser director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +26,500 | $0.00 | $0 | 26,500 | 19 d ago |
| Aug 27, 2026 | Lilach Payorski director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 19 d ago |
| Aug 27, 2026 | Karnit Goldwasser director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 19 d ago |
| Aug 27, 2026 | Shavit Beladev VP Plasma Operations | AGrant or award Employee Stock Option(right to buy)derivativeindirect: Held by trustee | +60,000 | $0.00 | $0 | 60,000 | 19 d ago |
| Aug 27, 2026 | Liron Reshef VP Human Resources | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +60,000 | $0.00 | $0 | 60,000 | 19 d ago |
| Aug 27, 2026 | Lilach Payorski director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 19 d ago |
| Aug 27, 2026 | Karnit Goldwasser director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 19 d ago |
| Aug 27, 2026 | Yael Brenner VP Quality | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +60,000 | $0.00 | $0 | 60,000 | 20 d ago |
| Aug 27, 2026 | Chaime Orlev Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +22,500 | $0.00 | $0 | 22,500 | 20 d ago |
| Aug 27, 2026 | Leon Recanati director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +26,500 | $0.00 | $0 | 26,500 | 20 d ago |
| Aug 27, 2026 | Benjamin Dekel director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +16,000 | $0.00 | $0 | 16,000 | 20 d ago |
| Aug 27, 2026 | Nir Livneh VP, General Counsel | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +29,485 | $0.00 | $0 | 29,485 | 20 d ago |
| Aug 27, 2026 | Assaf Itshayek director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +16,000 | $0.00 | $0 | 16,000 | 20 d ago |
| Aug 27, 2026 | Eran Nir VP, Operations | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +22,500 | $0.00 | $0 | 22,500 | 20 d ago |
| Aug 27, 2026 | Hanni Neheman VP, Marketing & Sales | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +15,000 | $0.00 | $0 | 15,000 | 20 d ago |
| Aug 27, 2026 | David Tsur director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +7,500 | $0.00 | $0 | 7,500 | 20 d ago |
| Aug 27, 2026 | Orit Pinchuk VP Regulatory Affairs | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +15,000 | $0.00 | $0 | 15,000 | 20 d ago |
| Aug 27, 2026 | Nir Livneh VP, General Counsel | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +60,000 | $0.00 | $0 | 60,000 | 20 d ago |
| Aug 27, 2026 | Hanni Neheman VP, Marketing & Sales | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +60,000 | $0.00 | $0 | 60,000 | 20 d ago |
| Aug 27, 2026 | Benjamin Dekel director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 20 d ago |
| Aug 27, 2026 | Chaime Orlev Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +90,000 | $0.00 | $0 | 90,000 | 20 d ago |
| Aug 27, 2026 | Orit Pinchuk VP Regulatory Affairs | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +60,000 | $0.00 | $0 | 60,000 | 20 d ago |
| Aug 27, 2026 | David Tsur director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 20 d ago |
| Aug 27, 2026 | Eran Nir VP, Operations | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +90,000 | $0.00 | $0 | 90,000 | 20 d ago |
| Aug 27, 2026 | Assaf Itshayek director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 20 d ago |
| Aug 27, 2026 | Leon Recanati director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 20 d ago |
| Aug 27, 2026 | Leon Recanati director | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +30,000 | $0.00 | $0 | 30,000 | 20 d ago |
| Aug 27, 2026 | Chaime Orlev Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivativeindirect: Held by trustee | +90,000 | $0.00 | $0 | 90,000 | 20 d ago |
| Sep 14, 2026 | David Tsur director | SOpen-market sale Ordinary Shares | -22,827 | $8.18 | $187k | 407,929 | 26 d ago |
| Sep 14, 2026 | Nir Livneh VP, General Counsel | MOption exercise Ordinary Shares | +10,000 | $5.37 | $54k | 10,000 | 26 d ago |
| Sep 14, 2026 | Yael Brenner VP Quality | MOption exercise Ordinary Shares | +5,000 | $5.93 | $30k | 11,266 | 26 d ago |
| Sep 14, 2026 | Nir Livneh VP, General Counsel | FTax withholding Ordinary Shares | -3,459 | $8.35 | $29k | 0 | 26 d ago |
| Sep 14, 2026 | Yael Brenner VP Quality | FTax withholding Ordinary Shares | -1,371 | $8.36 | $11k | 6,266 | 26 d ago |
| Sep 14, 2026 | Nir Livneh VP, General Counsel | MOption exercise Employee Stock Option (right to buy)derivativeindirect: Held by trustee | -10,000 | $0.00 | $0 | 0 | 26 d ago |
| Sep 14, 2026 | Yael Brenner VP Quality | MOption exercise Ordinary Shares | +5,000 | $5.93 | $30k | 11,266 | 26 d ago |
| Sep 14, 2026 | Yael Brenner VP Quality | FTax withholding Ordinary Shares | -1,371 | $8.36 | $11k | 6,266 | 26 d ago |
| Sep 14, 2026 | Yael Brenner VP Quality | MOption exercise Ordinary Shares | +5,000 | $5.93 | $30k | 11,266 | 26 d ago |
50 of 122 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Lilach Asher-Topilskydirector
- Shavit BeladevVP Plasma Operations
- Uri Botzerdirector
- Yael BrennerVP Quality
- Ishay Davididirector, owner
- Benjamin Dekeldirector
- Karnit Goldwasserdirector
- Boris GorelikVP, BD and Strategic Programs
- Assaf Itshayekdirector
- Nir LivnehVP, General Counsel
- Amir LondonChief Executive Officer
- Hanni NehemanVP, Marketing & Sales
- Eran NirVP, Operations
- Chaime OrlevChief Financial Officer
- Lilach Payorskidirector
- Orit PinchukVP Regulatory Affairs
- Leon Recanatidirector
- Liron ReshefVP Human Resources
- David Tsurdirector
Questions about KMDA
Answered from the filings on this page, as of the latest one.
Are insiders buying KMDA?
As of Sep 29, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 2 open-market sells worth $1.7M by 1 insider at KAMADA LTD in the last 90 days, net -$1.7M. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade KMDA on the open market?
David Tsur (director) sold $187k of KMDA on Sep 14, 2026 and filed the Form 4 on Sep 17, 2026. InsiderTell scored 27 (weak).
How many insiders file Form 4 at KAMADA LTD?
19 people have filed a Form 4 at KAMADA LTD, among them Lilach Asher-Topilsky (director), Shavit Beladev (VP Plasma Operations), Uri Botzer (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.